The Rays have been open to trading from their rotation this year and could do so again, with right-hander Zach Eflin one of the possible candidates. Marc Topkin of the Tampa Bay Times reports that the Astros, Braves and Cardinals are “among the teams expected to have strong interest” in the righty.
The Rays aren’t fully in the seller camp as they are currently 51-51 and just 4.5 games back of a playoff spot. However, their rotation health has improved as the season has gone along and given them a relative surplus. That has allowed them to explore deals that either address another area of the roster, bolster the prospect depth, save some money or some combination of those goals.
Each of Shane Baz, Jeffrey Springs and Drew Rasmussen began the season recovering from past arm surgeries. The Rays had a rotation of Eflin, Taj Bradley, Ryan Pepiot, Zack Littell and Aaron Civale for most of this year. Once they were ready to put Baz back into the rotation, they flipped Civale to the Brewers for a prospect and called up Baz.
A similar trade could make sense in the coming days. Pepiot is currently on the injured list with a knee infection but isn’t expected to be out for too long, while the Rays have Springs and Rasmussen both currently on rehab assignments. It’s therefore possible that they could trade a pitcher or two and still go through the stretch run with a healthy rotation. They have Tyler Alexander and Jacob Lopez around as depth and then Shane McClanahan should be back in the mix next year, after he recovers from his own elbow surgery.
Most of the pitchers in Tampa’s rotation mix are controllable for many years but Eflin and Littell are each slated for free agency after 2025. Eflin is a particularly sensible candidate for the budget-conscious club due to his contract. He signed a three-year, $40MM deal with Tampa going into 2023, with that deal being backloaded. He made $11MM last year and has that salary again here in 2024, with a jump to $18MM next year.
That is vaguely reminiscent of the extension that the Rays signed with Tyler Glasnow. While he was recovering from Tommy John surgery, Glasnow signed a two-year extension with the Rays which was also heavily backloaded. He was paid $5.35MM in 2023, his final arbitration season and a year in which he was expected to return from the surgery. The Rays also gained an extra year of control over him by giving him a $25MM salary for 2024.
He ended up returning in 2023 as expected, tossing 120 innings with a 3.53 earned run average. But before the big salary jump kicked in, he was traded to the Dodgers in a four-player deal that brought back Pepiot.
With Eflin set for a big raise next year and the Rays having plenty of other rotation options, he could be on the move shortly and should have plenty of suitors. He’s been a solid rotation stalwart for several years now, first with the Phillies and then with the Rays since signing his aforementioned deal. Dating back to the start of 2018, he has a 4.01 ERA in over 800 innings. His 22.2% strikeout rate in that time is close to par but he’s limited walks to a tiny rate of 4.9%.
Health has been an issue for Eflin, largely due to knee problems. He was limited to just 181 1/3 innings over 2021 and 2022, his final two years in Philadelphia, but has managed to stay on the mound more in Tampa. He logged 177 2/3 innings over 31 starts last year with a 3.50 ERA. This year, he’s already up to 19 starts and 110 innings with a 4.09 ERA. He had brief stints on the IL both years due to lower back issues but otherwise kept the train on the tracks.
That type of solid performance would have plenty of appeal and the listed teams each make sense as a landing spot. Atlanta lost Spencer Strider to UCL surgery and also saw Max Fried head to the injured list recently, along with depth options like Huascar Ynoa and Hurston Waldrep.
Currently, their rotation consists of Chris Sale, Reynaldo López, Charlie Morton and Spencer Schwellenbach, with various guys rotating through the back end. Bolstering that group with an external addition or two is plenty logical. Fried could perhaps be back but there’s risk in the current composition. Sale has a lengthy injury history and the club might want to hedge against him getting hurt again, even though he’s stayed healthy this year. López was just returned to a starting role after working as a reliever for a few years and could perhaps run out of gas later in the year. Morton’s gas tank might also be a factor just because he’s now 40 years old. Schwellenbach has been performing well but has just nine career starts in the majors.
The fact that Eflin is under contract for next year is likely appealing to Atlanta as well. Fried and Morton are both impending free agents, with the latter a possibility to consider retiring at season’s end. Strider will still be out of action by the start of 2025 so the on-paper rotation for next year will be Sale, López and a few question marks. Schwellenbach and some of the other young guys could step up and fill that in, but it’s no guarantee, so adding Eflin into the group would make sense.
The competitive balance tax may be a concern, as Atlanta is currently at $273MM, per the calculations of RosterResource. If they cross the third threshold of $277MM, they would not only incur a higher tax rate but their top pick in next year’s draft would also be moved back ten spots. Given where they are, they probably prefer to stay south of that line.
Eflin’s CBT hit is currently $13.33MM, based on the average annual value of his three-year, $40MM deal. However, a player’s CBT hit is recalculated when he is traded. If a deal comes together in the next few days, he would have about a third of this year’s $11MM salary remaining, in the ballpark of $3.67MM. Combined with his $18MM salary next year, that’s $21.67MM over a season and a third, making for a CBT hit of $16.3MM. If Atlanta acquires him for the final two months of the season, they would put a third of that figure on their CBT calculation for this year, or $5.43MM.
Assuming the RR calculations are close to correct, taking on Eflin’s entire contract might be problematic for Atlanta, so they might try to get creative and have Tampa eat a portion of the deal. Next year’s CBT hit is far lower, currently at $185MM, but they will undoubtedly add to that with some offseason moves.
The Astros have also had their share of rotation challenges this year, with Cristian Javier and José Urquidy both requiring Tommy John surgery. Luis Garcia has yet to return from his own TJS operation from last year while Lance McCullers Jr. is still trying to get back from his own elbow procedure. Justin Verlander is also on the shelf with a neck injury.
Their current rotation consists of Framber Valdez, Hunter Brown, Ronel Blanco, Spencer Arrighetti and Jake Bloss. Brown has recovered from an awful start to the season but each of Blanco, Arrighetti and Bloss is lacking in experience. Blanco only recently moved to the rotation after years of bullpen work while Arrighetti and Bloss are rookies who both have ERAs north of 5.60 so far this year.
Like Atlanta, Houston is set to pay the CBT this year but they have far more wiggle room. Houston’s CBT number is currently at $256MM, per RR. That’s just shy of the $257MM second line but crossing that only comes with a slight bump in tax rate and no draft pick penalties.
The Cardinals have a solid rotation front four consisting of Sonny Gray, Lance Lynn, Kyle Gibson and Miles Mikolas. With Steven Matz injured, they have had Andre Pallante holding down the fifth spot lately. Pallante has a decent 3.42 ERA in his nine starts but he has a subpar strikeout rate of 19.8% and a limited track record overall.
Adding Eflin could bolster that group for this year and 2025 as well. Both Gibson and Lynn are on one-year deals and could be free agents this winter. They both have club options on their deals but it’s not a guarantee that the Cardinals would pick either of those up. Unlike Atlanta and Houston, the CBT is not a huge concern in St. Louis. RR currently has the Cards at $215MM, which is $22MM south of the $237MM base threshold.
